CCM
SOPH icon

Coldstream Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

Coldstream Capital Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-224
Closed -$744 – 3031
2025
Q1 		$744 Buy
+224
New +$787 ﹤0.01% 3254

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Coldstream Capital Management's SOPH Position: Q2 2025 in Review

Coldstream Capital Management sold out of SOPHiA GENETICS (SOPH) in Q2 2025, closing a stake of 224 shares — an estimated $744 sold.

Coldstream Capital Management first reported a position in SOPH in Q1 2025 and held it in 1 quarter. The position peaked at $744 in Q1 2025. 32 funds tracked by Wall St. Rank hold SOPH as of Q2 2025.

  • Coldstream Capital Management reported no remaining SOPHiA GENETICS position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 224 SOPHiA GENETICS shares in Q2 2025, an estimated $744.
  • Coldstream Capital Management first reported a position in SOPHiA GENETICS in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's SOPHiA GENETICS position peaked at $744 in Q1 2025.
  • 32 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.